VANQUA BIO, INC. — Form D
VANQUA BIO, INC. of CHICAGO, IL, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-05. The offering totals $45.0M, of which $45.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-07-05
- Form: D
- Accession: 0001790072-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $45.0M
- Amount sold: $45.0M
- Investors: 12
- Date of first sale: 2024-02-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-517876
Issuer
- Name: VANQUA BIO, INC.
- CIK: 0001790072
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 1375 W Fulton Street, CHICAGO, IL, 60607
- Phone: 773-360-1673
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Mona Ashiya | Director | New York, NY |
| Uya Chuluunbaatar | Director | Chicago, IL |
| Bernard Davitian | Director | Chicago, IL |
| Jonathan Silverstein | Director | Chicago, IL |
| James Sullivan | Director | San Jose, CA |
| Rand Sutherland | Director | Chicago, IL |
| James Sullivan | Executive Officer | San Jose, CA |
| Stephen Squinto | Director | Stamford, CT |
| Sara Nayeem | Director | Menlo Park, CA |
| Jonathan Silverstein | Executive Officer | Chicago, IL |
| Viola Meehan | Executive Officer | Boston, MA |
Other filings by this issuer (2)
More